Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 West Introduces New Testing Platform | Contract Pharma
Breaking News

West Introduces New Testing Platform

West Analytical Services LLC has introduced a testing platform to help mitigate the risks associated with testing pulmonary and nasal drug products and their delivery devices. The company’s analytical services for pulmonary and nasal drug products include early-stage development, clinical development and post-product launch stages for pharma, biopharma and medical device clients. West provides testing for: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), nasal and oral sprays, and nebulizers at its FDA-registered, cGMP lab in Lionville, PA.
   
“Moving pulmonary and nasal drug products from early-stage development to the market is challenging for pharmaceutical, biopharmaceutical and medical device companies,” said Fran DeGrazio, vice president, marketing and strategic business development. “The challenges include testing the drug product and delivery device. Companies may not have a proven device selection process in place and may not have validated laboratory methods or instruments required to test the drug product and the device. Any misstep along the way runs the risk of costly project delays.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters